ArticlePDF Available

Cannabis: the forgotten sacred plant of India

Authors:

Abstract

The plant Cannabis sativa was cultivated in India since ancient times. Atherveda and Ayurveda hail the plant as sacred and medicinal. It was used as a source of fiber, food, oil and medicine and for recreation & spiritual purposes. Its cultivation and use dwindled since the British Government prohibited its use in 1930s. Delta-9-tetrahydrocannabinol (THC) is the most important component of its psychoactive substance. Natural receptors for THC are found throughout the human body called the ‘endocannabinoid system’. There is a lot of excitement the world over in recent times about its potential as a therapeutic agent. The low THC industrial variety is also being cultivated for seed, oil and fiber in many countries. The non-toxic seed and oil of industrial hemp are highly nutritious. The plant is useful as bio-fuel, eco-friendly building material and phytoremediator. Indian government should also encourage and facilitate researchers of traditional medicine to explore the potential of this versatile native plant while the world benefits from it.
www.jahm.in
(ISSN-2321-1563)
92
SHORT REVIEW ARTICLE
CANNABIS: THE FORGOTTEN SACRED PLANT OF INDIA
SHARDA NARENDRA BAPAT
ABSTRACT
The plant Cannabis sativa was cultivated in India since ancient times. Atherveda and Ayurveda hail the plant as
sacred and medicinal. It was used as a source of fiber, food, oil and medicine and for recreation & spiritual
purposes. Its cultivation and use dwindled since the British Government prohibited its use in 1930s. Delta-9-
tetrahydrocannabinol (THC) is the most important component of its psychoactive substance. Natural receptors
for THC are foud throughout the hua od alled the edoaaioid sste. There is a lot of
excitement the world over in recent times about its potential as a therapeutic agent. The low THC industrial
variety is also being cultivated for seed, oil and fiber in many countries. The non-toxic seed and oil of industrial
hemp are highly nutritious. The plant is useful as bio-fuel, eco-friendly building material and phytoremediator.
Indian government should also encourage and facilitate researchers of traditional medicine to explore the
potential of this versatile native plant while the world benefits from it.
KEYWORDS: Cannabis, Cannabis sativa, cannabinoids Indian hemp, Ayurveda, endocannabinoid system,
Pharmacology
Corresponding author email: shardabapat@hotmail.com
Access this article online: www.jahm.in
Published by Atreya Ayurveda Publications under the license CC-by-NC.
Jour. of Ayurveda & Holistic Medicine
Volume-III, Issue-V
93
INTRODUCTION:
Cannabis sativa (C. sativa), also known as the
Indian hemp, is a herbaceous annual which
has been cultivated in India since ancient
times. Atharva Veda hails the hag plat as
oe of the fie sared plats.
[1]
It has been
used over the ages, as a source of fiber, food,
oil and medicine as well as for recreational,
religious and spiritual purposes. The British
Government of India prohibited consumption
of cannabis resin (charas) in India in the
93s. Sie the the cultivation and use of C.
sativa dwindled.
[2]
Presently, the plant is popularly known only as
a source of narcotics in various forms and
names in India such as bhang, charas, ganja,
marijuana, hashish, weed, grass etc. It is illegal
to produce, manufacture, possess, sell,
purchase, transport, use, consume, import,
export any narcotic drug or psychotropic
substance except for medical or scientific
purposes under the Narcotic Drugs and
Psychotropic Substances Act in India.
[3]
The
maximum penalty for repeat offence can be as
high as a death penalty. There are no clear
guidelines and jurisdiction for obtaining the
license for medical/scientific research. This has
made research extremely difficult in most
states of India.
Medicinal qualities of the plant and its narcotic
principle have been long known traditionally in
India. It was used as a house hold remedy and
by Hakims and Vaidyas as appetizer,
aphrodisiac, pain-reliever, antispasmodic,
antidiarrheal as well as a diuretic.
[2]
Many of the traditional uses need research for
finding innovative remedies. For example,
Ayurveda suggests use of the plant after
areful purifiatio oilig ith o ilk to
reduce toxic effects. The usage of this plant as
a potent analgesic is described in many
ancient texts and traditional practices. The
uses range from medicated milk to external
fomentation and fumigation for pain relief
(Gogte, 2000).
[4]
There is renewed interest all over the world in
this plant for its medicinal as well as other
potential uses. As a result, many countries
have decriminalized or legalized possession of
narcotics for medical purpose and some have
even legalized its use for recreational
purposes.
[5]
Recent systematic and critical
review from Israel about the effect of
legalization of cannabis for therapeutic
purposes concluded that it may not pose
substantial threat to public health and safety.
[6]
Recent legalization of its use in other
countries offers opportunity for fresh
assessment of its social impact.
Jour. of Ayurveda & Holistic Medicine
Volume-III, Issue-V
94
The sticky resin produced by the flowers and
top leaves of the plant contains a number of
psychoactive substances called cannabinoids
of which delta-9-tetrahydrocannabinol (THC) is
the most important. Receptors for THC were
identified as part of an endocannabinoid
system in the human body and their presence
noted in various tissues ranging from brain to
periphery. Anatomical, physiological and
pharmacological studies have shown that the
endocannabinoid system is widely distributed
throughout the gut, with regional variation
and organ-specific actions. It is involved in the
regulation of food intake, nausea and emesis,
gastric secretion and gastro protection, gastro-
intestinal motility, ion transport, visceral
sensation, intestinal inflammation and cell
proliferation in the gut.
[7]
Researchers of
modern medicine have endorsed its potential
as an antiemetic specially in cancer patients.
[8]
There is evidence of its effectiveness in the
treatet of Crohs disease.
[9]
Cannabis based medicine is approved for the
treatment of pain and spasticity in multiple
sclerosis in many countries.
[10]
Its potential
role in the treatment of epilepsy and
rheumatoid arthritis is also being explored.
[11-
12]
Apart from the psychoactive substance
though, the plant has many uses which are
being recognized all over the world. Efforts for
research and cultivation of low THC variety of
the specie called Industrial Hemp are
increasingly being undertaken in many
countries across the world. Industrial hemp
heeforth alled as hep is a race of C.
sativa with low levels of THC and higher levels
of cannabidiol(CBD). CBD actually reduces the
psychoactive effects of THC. Hence, CBD:THC
ratio is important in determining the value of
the drug. THC level of <0.3% cannot produce
any psychoactive effects. Low THC caultivars
are actively bred in Industrial hemp
cultivation. The seed of industrial hemp does
not contain THC. Methods of cultivation of
hemp differ according to the desired use viz.
fiber or seed.
[13]
The seed of hemp holds some wonderful
qualities and has great potential as a source of
nutrition as well as traditional medicine for
Indian population whose staple diet is mostly
plant based. Whole hempseed has
approximately 20-25% protein, 25-35% oil, 20-
30% carbohydrates and 10-15% insoluble fiber
apart from array of minerals such as
phosphorous, potassium, magnesium, sulphur
and calcium, iron, zinc, carotene and dietary
fiber. It is rich in vitamins A, C and E. It has all 8
essential amino acids. It contains edestein,
which is similar to albumin. The oil derived
Jour. of Ayurveda & Holistic Medicine
Volume-III, Issue-V
95
from hemp seed is highly polyunsaturated and
its potential uses range from fuel to raw
material for soaps and cosmetics. The 3:1 ratio
of linoleic and linolenic acid in hemp oil has
been claimed to be optimal for human
nutrition. In addition, it also contains Gamma-
linolenic acid (GLA) and terpenes which may
render anti-inflammatory, anti-allergic, and
cytoprotective pharmacological properties. It
also contains some other useful trace
elements such as β-sitosterol and methyl
salicylate.
[14-15]
Hemp is a versatile plant and can produce
number of high quality products e.g. fabrics
and yarns, carpets, paper etc. It can be used in
building materials as a composite, insulation,
biodegradable plastics. The hemp boards
made from the plant are lighter, stronger and
biodegradable. The broken woody core of the
plant, a by-product of fiber-making, can be
used as animal bedding and animal-feed. It
therefore has a potential for development of
cottage industry. Hemp also has an advantage
that it needs fewer pesticides, herbicides than
alternative fiber crops like cotton. The
Fiber/hemp seed crops do not require weed
killer. It can also reduce soil nutrient loss and
erosion and improve soil structure.
[16]
It has
potential as a phytoremediator due to its
strong and deep growing tap root system.
Various countries are revamping their national
policies for supporting use of cannabis for
therapeutic purposes. Indian medical
fraternity should urge the Indian government
to facilitate research to explore medical and
nutritional potential of this versatile native
plant.
Acknowledgements: Special thanks to Vaidya
Girish Tillu for his valuable inputs and Mr.
Jahan Pestonjamas for literature on Industrial
Hemp.
REFERENCES:
1. Report of the Indian Hemp Drugs Commission.
Simla, India: Government Central Printing House.
1894.Chapter IX: Social and Religious Customs.
2. Chopra I, Chopra R. Use of cannabis drugs in India.
United Nations Office on Drugs and Crime-Bulletin
on Narcotics 1957;1-002:4-29
3. Narcotic Drugs and Psychotropic Substances Act in
India, 1985. Page 9-Chapter III:8(c)
4. Vaidya V M Gogte. Ayurvedic Pharmacology and
Therapeutic Uses of Medicinal Plants. Bharatiya
Vidya Bhavan, Mumbai. 2000; 447-50
5. The economist, T.W. The difference between
legalisation and decriminalisation. The Economist
explains. Weblog. [Online] Available from:
http://www.economist.com/blogs/economist-
explains/2014/06/economist-explains-
10?fsrc=scn/tw/te/bl/ed/thedifferencebetweenleg
alisationanddecriminalisation [Accessed 11
November 2015].
Jour. of Ayurveda & Holistic Medicine
Volume-III, Issue-V
96
6. Sznitman S, Zolotov Y. Cannabis for Therapeutic
Purposes and public health and safety: A systematic
and critical review. Int J Drug Policy 2015;26:20-29
7. Izzo AA, Sharkey KA. Cannabinoids and the gut: new
developments and emerging concepts. Pharmacol
Ther 2010;126:21-38
8. Doblin RE, Kleiman MA. Marijuana as antiemetic
medicine: a sure of oologists eperiees ad
attitudes. J Clin Oncol 1991;9:1314-9
9. Naftali t, Bar-lev Schleider L, Dotan I, Lansky EP,
Sklerovshy Benjaminov F, Konikoff FM. Cannabis
idues a liial respose i patiets ith Crohs
disease: a prospective placebo-controlled study.
Clin Gastroenterol Hepatol 2013;11:1276-80
10. Baker D, Pryce G, Jackson SJ, Bolton C, Giovannoni
G. The biology that underpins the therapeutic
potential of cannabis-based medicines for the
control of spasticity in multiple sclerosis. Mult Scler
Relat Disord 2012;1:64-75
11. Hofmann M, Frazier C. Marijuana,
endocannabinoids, and epilepsy:Potential and
challenges for improved therapeutic intervention.
Exp Neurol 2013;244:43-50
12. Gui H, Tong Q, Qu W, Mao CM, Dai SM. The
endocannabinoid system and its therapeutic
implications in rheumatoid arthritis. Int
Immunopharmacol 2015;26:86-91
13. Grotenhermen F, M. Karus, D. Hohmeyer. THC-
limits for food: a scientific study. Journal of the
International Hemp Association 1998, 5:101-105
14. Deferne JL, Pate DW. Hemp seed oil: A source of
valuable essential fatty acids. Journal of the
International Hemp Association 1996;3:4-7
15. Leizer C, Ribnicky D, Poulev A, Dushenkov S, Raskin
I. The Composition of Hemp Seed Oil and its
potential as an important source of nutrition.
Journal of Nutraceuticals, functional & medical
foods 2000;2:35-53
16. Merfield C. Industrial Hemp and its potential for
New Zealand: A report for the 1999 Kellogg Rural
Leadership Course 1999
Cite this article as: Sharda Narendra Bapat,
Cannabis: the forgotten sacred plant of India, J of
Ayurveda and Hol Med (JAHM).2015;3(4):92-96
Source of support: Nil, Conflict of interest: None
Declared.
... The hemp seed also contains α-, β-and γtocopherols, where the proportion of gamma tocopherols are higher than that of other two, and both gamma and alpha tocopherols have shown to have anti-inflammatory properties in injuries where inflammation takes place (Crescente et al., 2018). The pharmacological and physiological study of hemp seed has shown that its actions are organ-specific which regulate the taken food, gastric secretion, gastrointestinal mobility, visceral sensation and intestinal inflammation of the gut (Bapat, 2015). ...
... It is also reported that when the diet is rich with hemp seed then it guards against neurodegenerative disease (Leonard et al., 2020). Tetrahydrocannabinol and other ingredients of hemp, in addition to other benefits, it is also found to be neuroprotective (Bapat, 2015;Baron, 2018). Some researchers have reported that when the rats were on diet with hemp seed, then they have shown noticeable longevity, the performance of memory was better and anti-ageing genes were also expressed. ...
Article
Full-text available
Hemp seeds are gaining increasing attention in the realm of research due to their multifaceted nutritional and pharmaceutical properties. Notably, these seeds offer a rich source of protein, carbohydrates, polyunsaturated fatty acids, vitamins, and minerals, making them a valuable addition to one’s diet therefore, growing interest among researchers globally. A comprehensive literature review was conducted on the prominent databases Scopus, Elsevier, and PubMed using the keywords "Hempseed," "Phytochemistry," "Nutraceuticals," and their food and feed applications. Studies suggest that these compounds exhibit therapeutic potential against conditions such as epilepsy, certain neurological disorders (Parkinson’s and Alzheimer’s diseases), and cardiovascular issues. Additionally, hemp seeds possess other notable properties, such as anti-cancer, anti-inflammatory, and immunomodulatory effects. They are also used as a dietary supplement to alleviate headaches, insomnia, high cholesterol levels, and premenstrual syndrome symptoms in women. Hempseed oil, powder, and flour are utilized to enhance the phenolic activity and antioxidant properties of food products. Additionally, hempseed cake, generated after cold pressing, boasts a high protein concentration, making it a valuable feed for ruminants. However, further research and clinical trials are necessary to fully understand and harness the potential of hemp seeds for functional foods and nutraceutical applications.
... Violation of this may be punishable with maximum penalty for repeat offence can be as high as a death penalty. [32] In 11 US states (Alaska, California, Colorado, Illinois, Maine, Massachusetts, Michigan, Nevada, Oregon, Vermont and Washington, and the District of Columbia), recreational or 'non-medical cannabis has been legalized and was legalized federally in Canada on 17 October 2018. [33] Opioids Opioid use disorder and opioid dependence are a problem of global concern. ...
Article
Full-text available
Introduction: Addictive drugs and its abuse are a major health as well as social concern all over the world. Around 40 million people are regularly abusing drugs throughout the world. The problem is matter of concern for India as well. Most importantly substance abuse is widely getting popular among young generations including medical students. This article is an endeavor to address current status of addictive drugs. Methods: Scientific literature regarding addiction were collected from various data bases from Google Scholar, PubMed, Embase, Indexed Research Journals, and Textbooks using the keywords Addiction, Substance abuse, Addictive, Drug dependency. The collected data were critically reviewed and results were drawn. Results: The critical review of the data revealed that, nearly ten different types of addictive drugs are used currently. The majority of users are from adolescent age or students. Even though both sexes are involved prevalence rate is more in males. Among all the additives alcohol and tobacco are the most common. The common health issues include tolerance, physical dependence, sensitization, craving, relapse, depression, intense anxiety, hopelessness, helplessness, and irritability. The statutory control over narcotic drugs was exercised in India through a number of Central and State enactments like the opium Act, 1857, the Opium Act, 1878 and the Dangerous Drugs Act, 1930. But in spite of all these efforts the drug dependence is a major concern for globe. Conclusion: Drug abuse and addiction are affecting the quality of life of people around the world and hence awareness about the health hazards and availability of de-addiction measures for all strata of population is recommended.
... Indian hemp (or cannabis) have 5 -20 % THC (Pospišil, 2013). The British government of India prohibited consumption of C. indica L. in the 1930's (Bapat et al., 2015). European countries set their own national drug laws, although all of them are parties of the UN Single Convention (Bifulco and Pisanti, 2015). ...
Article
Full-text available
Long before they were even properly named, plants form Cannabis genus (C. indica L., C. sativa L. and C. ruderalis L.) had their usefulness in the folk medicine. Recently, it has been scientifically proven that cannabinoids mainly act through two types of endocannabinoid receptors in the central nervous system (CB1) and immune cells (CB2). The usage can be either from recreational usage in glaucoma or in research for acute and chronic pain therapy. Some clinical studies support the use of hemp oil and hemp seed in the pain medicine. However, until today, there is still no evidence to suggest that medical cannabis can be used solely as cure, but the use of hemp seed and oil from hemp seeds or flowers in practice, refers to symptomatic treatment as adjunctive therapy. Treatment consists of an individual dose titration phase (with patient supervision) of delta-9-tetrahidrocannabinol (THC) or cannabidiol (CBD) and a maintenance phase. The main goal of this is study was the overview of therapeutic benefit to the familiar and wildly used hemp plant in acute and chronic pain, mostly because of its cost-effectiveness. Overall, this review paper highlights more possibilities of hemp plant usage in further symptomatic pain treatments.
... Cannabis is also present in archaeological artifacts depicting Soma as a composite psychoactive substance comprising Ephedra and Cannabis (Merlin 2003). The word 'Bhanga' has been described in Atharvaveda among five sacred plants along with Soma (Bapat 2015). There is no direct reference to Bhanga in Samhitas (Basic canonical Hindu scriptures comprising hymns, prayers, and liturgical formulas), including the Rig Veda, the Yajur Veda, and the Sama Veda, and the Atharva Veda (https://www.merriam-webster.com). ...
Chapter
Ayurveda has delineated a unique classification entitled ‘Upavisha varga’ comprising of certain semi-poisonous medicinal plants. Bhanga (Cannabis) is one amongst them in this category depicting its narcotic nature from Sanskrit synonyms. Bhanga has been in use since the Vedic age under the controversial plant of Soma that had special importance due to its mystical effects on the brain. All the texts of Ayurveda have described Bhanga in detail of its pharmacological properties, indications, various dosage forms, doses, pharmacovigilance aspects, and its extensive use in Indian Alchemy. The following review throws light on the occurrence and usage of Bhanga in excerpts from classical texts of Ayurveda from a pharmacological and pharmaceutical point of view thus, providing a rationale for its safe medical usage.KeywordsAyurveda Bhanga CannabisClassicalEvidenceReviewUpavishaVijaya
... Cannabis is also present in archaeological artifacts depicting Soma as a composite psychoactive substance comprising Ephedra and Cannabis (Merlin 2003). The word 'Bhanga' has been described in Atharvaveda among five sacred plants along with Soma (Bapat 2015). There is no direct reference to Bhanga in Samhitas (Basic canonical Hindu scriptures comprising hymns, prayers, and liturgical formulas), including the Rig Veda, the Yajur Veda, and the Sama Veda, and the Atharva Veda (https://www.merriam-webster.com). ...
Chapter
Bhanga (Cannabis) has been reported with numerous therapeutic, traditional, commercial, and sacred uses in India and across the globe. Its uses are deeply rooted in the cultural, social, and economic lives of the people. The inclusion of Cannabis under ‘Scheduled E1’ drugs in India restricts its use. However, being a crop of economic and medicinal importance, the pharmaceutical and various other sectors are showing much interest in the plant. The present review article delineates traditional, culinary, cosmetic, ritual, social, spiritual, recreational, economic, and therapeutic uses of Cannabis. The review illustrates various uses of Cannabis across the globe; noted from articles, publications, and books providing description of various parts, viz. leaves and seeds (Bhanga), flowering and fruiting tops (Ganja), resin (Charas), extract, tincture, and whole plant, stalks (Fibers). The review may be helpful to researchers, clinicians, and pharmaceutical companies to carry out further research for developing cost-effective healthcare options.
... Cannabis has been widely recognized for its therapeutic purposes in ancient times, and evidence suggest it has been used for treating a vast range of medical indications in different regions of the world, including China (Zuardi, 2006), India (Bapat, 2015), Africa and the Middle East (Mechoulam and Ben-Shabat, 1999). The use of cannabis for medical purposes initiated in Western countries following the medical and scientific work of Sir William B. O'Shaughnessya 19th century British physician who worked as Professor of Chemistry and Materia Medica in Calcutta, India (Kalant, 2001). ...
Article
Background Although medical cannabis regulations are emerging in many places around the world, a contentious conundrum remains within the medical establishment regarding the appropriate part that cannabis may have in the provision of health care. Nurses have an indispensable role in the care management of patients, and given the consideration of cannabis as a possible treatment, they are warranted to be aware of its medical properties, as well as to be able to adequately answer patient queries. Nevertheless, very little is currently known about nurses’ perceptions related to medical cannabis. Objective To assess attitudes, beliefs and knowledge about medical cannabis among nursing students. Methods Cross-sectional study in two universities: XXX University (XU) in New Jersey and YYY University (YU) in Israel. In addition to demographic data, the survey instrument included questions about attitudes, beliefs, knowledge, and training. Results Overall, 387 students participated, mainly females (87.8%). The vast majority from both sub-groups stated they would recommend cannabis to their patients if allowed to do so (91.2%), and were in agreement that medical cannabis is associated with significant benefits for physical (93.5%) and mental (87.8%) health. Compared to the YU sub-group, more students from XU stated that they feel prepared to answer patient questions about medical cannabis (19.5% vs. 33.5%, respectively; χ²=9.74, p<0.01). Although the majority of respondents stated they have not received any formal education related to medical cannabis, they expressed endorsement for such training and education. Conclusions In light of the expanding number of patients who use medical cannabis, this study highlights the importance of incorporating medical cannabis education for nurses in academic and clinical curricula.
Article
Full-text available
The fatty acid and natural product content of hemp seed oil was analyzed by GC-MS and LC-MS. The presence of linoleic acid (LA) and -linolenic acid (LNA) were confirmed in their previously reported ratio of 3:1 LA:LNA. The presence of -caryophyllene (740 mg/L), myrcene (160 mg/L), -sitosterol (100-148 g/L) and trace amounts of methyl salicylate was observed in the oil which had not been previously reported. Trace amounts of cannabidiol (CBD) were also detected. Bioassays were performed with the oil to determine its effectiveness as an antimicrobial agent. Some bioactivity was observed during the primary screening. (Article copies available for a fee from The Haworth Document Delivery Service: 1-800-342-9678. E-mail address: Website: )
Article
Since the discovery of the endogenous receptor for Δ(9)-tetrahydrocannabinol, a main constituent of marijuana, the endocannabinoid system (comprising cannabinoid receptors and their endogenous ligands, as well as the enzymes involved in their metabolic processes) has been implicated as having multiple regulatory functions in many central and peripheral conditions, including rheumatoid arthritis (RA). RA is an immune-mediated inflammatory disease that is associated with the involvement of many kinds of cells (such as fibroblastlike synoviocytes [FLSs], osteoclasts, T cells, B cells, and macrophages) and molecules (such as interleukin-1β, tumor necrosis factor-α, interleukin-6, matrix metalloproteinases [MMPs], and chemokines). Increasing evidence suggests that the endocannabinoid system, especially cannabinoid receptor 2 (CB2), has an important role in the pathophysiology of RA. Many members of the endocannabinoid system are reported to inhibit synovial inflammation, hyperplasia, and cartilage destruction in RA. In particular, specific activation of CB2 may relieve RA by inhibiting not only the production of autoantibodies, proinflammatory cytokines, and MMPs, but also bone erosion, immune response mediated by T cells, and the proliferation of FLSs. In this review, we will discuss the possible functions of the endocannabinoid system in the modulation of RA, which may be a potential target for treatment. Copyright © 2015. Published by Elsevier B.V.
Article
Background The use of Cannabis for Therapeutic Purposes (CTP) has recently become legal in many places. These policy and legal modifications may be related to changes in cannabis perceptions, availability and use and in the way cannabis is grown and sold. This may in turn have effects on public health and safety. To better understand the potential effects of CTP legalization on public health and safety, the current paper synthesizes and critically discusses the relevant literature. Methods Twenty-Eight studies were identified by a comprehensive search strategy, and their characteristics and main findings were systematically reviewed according to the following content themes: CTP and illegal cannabis use; CTP and other public health issues; CTP, crime and neighbourhood disadvantage. Results The research field is currently limited by a lack of theoretical and methodological rigorous studies. The review shows that the most prevalent theme of investigation so far has been the relation between CTP and illegal cannabis use. In addition, the literature review shows that there is an absence of evidence to support many common concerns related to detrimental public health and safety effects of CTP legalization. Conclusion Although lack of evidence provides some reassurance that CTP legalization may not have posed a substantial threat to public health and safety, this conclusion needs to be examined in light of the limitations of studies conducted so far. Furthermore, as CTP policy continues to evolve, including incorporation of greater commercialization, it is possible that the full effects of CTP legalization have yet to take place. Ensuring study quality will allow future research to better investigate the complex role that CTP plays in relation to society at large, and public health and safety in particular.
Article
Cannabis-based medicines have recently been approved for the treatment of pain and spasticity in multiple sclerosis (MS). This supports the original perceptions of people with MS, who were using illegal street cannabis for symptom control and pre-clinical testing in animal models of MS. This activity is supported both by the biology of the disease and the biology of the cannabis plant and the endocannabinoid system. MS results from disease that impairs neurotransmission and this is controlled by cannabinoid receptors and endogenous cannabinoid ligands. This can limit spasticity and may also influence the processes that drive the accumulation of progressive disability.
Article
Phytocannabinoids isolated from the cannabis plant have broad potential in medicine that has been well recognized for many centuries. It is presumed that these lipid soluble signaling molecules exert their effects in both the central and peripheral nervous system in large part through direct interaction with metabotropic cannabinoid receptors. These same receptors are also targeted by a variety of endogenous cannabinoids including 2-arachidonoyl glycerol and anandamide. Significant effort over the last decade has produced an enormous advance in our understanding of both the cellular and the synaptic physiology of endogenous lipid signaling systems. This increase in knowledge has left us better prepared to carefully evaluate the potential for both natural and synthetic cannabinoids in the treatment of a variety of neurological disorders. In the case of epilepsy, long standing interest in therapeutic approaches that target endogenous cannabinoid signaling systems are, for the most part, not well justified by available clinical data from human epileptics. Nevertheless, basic science experiments have clearly indicated a key role for endogenous cannabinoid signaling systems in moment to moment regulation of neuronal excitability. Further it has become clear that these systems can both alter and be altered by epileptiform activity in a wide range of in vitro and in vivo models of epilepsy. Collectively these observations suggest clear potential for effective therapeutic modulation of endogenous cannabinoid signaling systems in the treatment of human epilepsy, and in fact, further highlight key obstacles that would need to be addressed to reach that goal.
Article
Cannabis has been used to treat gastrointestinal (GI) conditions that range from enteric infections and inflammatory conditions to disorders of motility, emesis and abdominal pain. The mechanistic basis of these treatments emerged after the discovery of Delta(9)-tetrahydrocannabinol as the major constituent of Cannabis. Further progress was made when the receptors for Delta(9)-tetrahydrocannabinol were identified as part of an endocannabinoid system, that consists of specific cannabinoid receptors, endogenous ligands and their biosynthetic and degradative enzymes. Anatomical, physiological and pharmacological studies have shown that the endocannabinoid system is widely distributed throughout the gut, with regional variation and organ-specific actions. It is involved in the regulation of food intake, nausea and emesis, gastric secretion and gastroprotection, GI motility, ion transport, visceral sensation, intestinal inflammation and cell proliferation in the gut. Cellular targets have been defined that include the enteric nervous system, epithelial and immune cells. Molecular targets of the endocannabinoid system include, in addition to the cannabinoid receptors, transient receptor potential vanilloid 1 receptors, peroxisome proliferator-activated receptor alpha receptors and the orphan G-protein coupled receptors, GPR55 and GPR119. Pharmacological agents that act on these targets have been shown in preclinical models to have therapeutic potential. Here, we discuss cannabinoid receptors and their localization in the gut, the proteins involved in endocannabinoid synthesis and degradation and the presence of endocannabinoids in the gut in health and disease. We focus on the pharmacological actions of cannabinoids in relation to GI disorders, highlighting recent data on genetic mutations in the endocannabinoid system in GI disease.
Government Central Printing House. 1894.Chapter IX: Social and Religious Customs
  • India Simla
Simla, India: Government Central Printing House. 1894.Chapter IX: Social and Religious Customs.